Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 1
1997 3
1998 1
1999 1
2000 2
2002 2
2006 5
2007 7
2008 1
2009 2
2010 7
2011 7
2012 16
2013 13
2014 17
2015 16
2016 13
2017 20
2018 16
2019 15
2020 22
2021 17
2022 11
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Nutritional medicine as mainstream in psychiatry.
Sarris J, Logan AC, Akbaraly TN, Amminger GP, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN; International Society for Nutritional Psychiatry Research. Sarris J, et al. Among authors: amminger gp. Lancet Psychiatry. 2015 Mar;2(3):271-4. doi: 10.1016/S2215-0366(14)00051-0. Epub 2015 Feb 25. Lancet Psychiatry. 2015. PMID: 26359904 Review.
Age of onset of mental disorders: a review of recent literature.
Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustün TB. Kessler RC, et al. Among authors: amminger gp. Curr Opin Psychiatry. 2007 Jul;20(4):359-64. doi: 10.1097/YCO.0b013e32816ebc8c. Curr Opin Psychiatry. 2007. PMID: 17551351 Free PMC article. Review.
Medicinal cannabis for the treatment of anxiety disorders.
Berger M, Amminger GP, McGregor IS. Berger M, et al. Among authors: amminger gp. Aust J Gen Pract. 2022 Aug;51(8):586-592. doi: 10.31128/AJGP-04-21-5936. Aust J Gen Pract. 2022. PMID: 35908759 Free article.
Influence of cannabis use on incidence of psychosis in people at clinical high risk.
Chester LA, Valmaggia LR, Kempton MJ, Chesney E, Oliver D, Hedges EP, Klatsa E, Stahl D, van der Gaag M, de Haan L, Nelson B, McGorry P, Amminger GP, Riecher-Rössler A, Studerus E, Bressan R, Barrantes-Vidal N, Krebs MO, Glenthøj B, Nordentoft M, Ruhrmann S, Sachs G, McGuire P; EU-GEI High Risk Study Group. Chester LA, et al. Among authors: amminger gp. Psychiatry Clin Neurosci. 2023 Sep;77(9):469-477. doi: 10.1111/pcn.13555. Epub 2023 May 13. Psychiatry Clin Neurosci. 2023. PMID: 37070555 Free PMC article.
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, Quinn AL, Catania L, Kazantzis N, McGorry PD, Berk M. Davey CG, et al. Among authors: amminger gp. Lancet Psychiatry. 2019 Sep;6(9):735-744. doi: 10.1016/S2215-0366(19)30215-9. Epub 2019 Jul 29. Lancet Psychiatry. 2019. PMID: 31371212 Clinical Trial.
Global research priorities for youth mental health.
Mei C, Fitzsimons J, Allen N, Alvarez-Jimenez M, Amminger GP, Browne V, Cannon M, Davis M, Dooley B, Hickie IB, Iyer S, Killackey E, Malla A, Manion I, Mathias S, Pennell K, Purcell R, Rickwood D, Singh SP, Wood SJ, Yung A, McGorry PD. Mei C, et al. Among authors: amminger gp. Early Interv Psychiatry. 2020 Feb;14(1):3-13. doi: 10.1111/eip.12878. Early Interv Psychiatry. 2020. PMID: 31960595
Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis.
Baldwin H, Radua J, Antoniades M, Haas SS, Frangou S, Agartz I, Allen P, Andreassen OA, Atkinson K, Bachman P, Baeza I, Bartholomeusz CF, Chee MWL, Colibazzi T, Cooper RE, Corcoran CM, Cropley VL, Ebdrup BH, Fortea A, Glenthøj LB, Hamilton HK, Haut KM, Hayes RA, He Y, Heekeren K, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Klaunig MJ, Koike S, Koppel A, Kristensen TD, Bin Kwak Y, Kwon JS, Lawrie SM, Lebedeva I, Lee J, Lin A, Loewy RL, Mathalon DH, Michel C, Mizrahi R, Møller P, Nelson B, Nemoto T, Nordholm D, Omelchenko MA, Pantelis C, Raghava JM, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Smigielski L, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Tang J, Theodoridou A, Thomopoulos SI, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TAMJ, Van Erp TGM, Waltz JA, Westlye LT, Wood SJ, Zhou JH, McGuire P, Thompson PM, Jalbrzikowski M, Hernaus D, Fusar-Poli P; ENIGMA Clinical High Risk for Psychosis Working Group. Baldwin H, et al. Transl Psychiatry. 2022 Jul 26;12(1):297. doi: 10.1038/s41398-022-02057-y. Transl Psychiatry. 2022. PMID: 35882855 Free PMC article.
Novel biotherapies are needed in youth mental health.
Amminger GP, Berger M, Rice SM, Davey CG, Schäfer MR, McGorry PD. Amminger GP, et al. Australas Psychiatry. 2017 Apr;25(2):117-120. doi: 10.1177/1039856217698237. Epub 2017 Mar 7. Australas Psychiatry. 2017. PMID: 28375061 Review.
179 results